Posted in | News | Business | Precious Metal

DNA Completes Acquisition of Tectonic Resources’ Montauban Mine Property Claims

DNA Precious Metals, Inc. ("DNA" or "the Company") today announced that the Company has completed the acquisition for an undivided one hundred percent (100%) interest in all of the Montauban Mine Property mining claims of Tectonic Resources. The newly-acquired 57 contiguous mining claims ("Mineral Claims") cover an approximate surface area of 2,560 hectares.

These new mining assets represent another significant expansion to DNA's currently 100% claimed Montauban Mine Property mining claims. The Mineral Claims acquisition solidifies the Company's Montauban Mine Property bundle, while expanding exploration and mining potential. Highlights of historical selected grab samples include 17.14% Zinc, 483 g/t Ag and 14.96% Zinc and 1.92% Lead.

"We are extremely excited with this latest acquisition as it provides the Company with the potential to significantly increase the Company's long-term exploration program while enhancing the investment value of these mining claims," said James Chandik, President & Chief Executive Officer of DNA Precious Metals, Inc.

About DNA Precious Metals, Inc.

DNA Precious Metals, Inc. is focused on near-term production of the Montauban tailings mine in the Province of Quebec, Canada with an aggressive search for economic production assets. The company trades on the OTCQB market in the United States under the stock symbol DNAP. For more information, please go to www.DNAPreciousMetals.com.

On Behalf of the Company

James Chandik, President & Chief Executive Officer.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.